Insulet Corporation (PODD) CEO Jim Hollingshead on Q2 2022 Results - Earnings Call Transcript

Insulet Corporation (NASDAQ:PODD) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET

Company Participants

Deborah Gordon - Vice President, Investor Relations

Jim Hollingshead - President and Chief Executive Officer

Wayde McMillan - Executive Vice President and Chief Financial Officer

Bret Christensen - Executive Vice President and Chief Commercial Officer

Conference Call Participants

Larry Biegelsen - Wells Fargo

Robbie Marcus - JP Morgan

Travis Steed - Bank of America

Steve Lichtman - Oppenheimer

Chris Pasquale - Nephron Research

Joanne Wuensch - Citi

Cecilia Furlong - Morgan Stanley

Margaret Kaczor - William Blair

Jayson Bedford - Raymond James

Brian Kennedy - Cowen

Matthew O’Brien - Piper Sandler

Jeff Johnson - Baird

Operator

Good afternoon, ladies and gentlemen and welcome to the Insulet Corporation Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct the question-and-answer session, and instructions will follow at that time. As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Deborah Gordon, Vice President of Investor Relations.

Deborah Gordon

Thank you, Dilem. Good afternoon, and thank you for joining us for Insulet’s second quarter 2022 earnings call. With me today are; Jim Hollingshead, President and Chief Executive Officer; and Wayde McMillan, Executive Vice President and Chief Financial Officer; Bret Christensen, our Executive Vice President and Chief Commercial Officer, is also with us today for the Q&A portion of our call. Both the replay of this call and the press release discussing our 2022 second quarter results and 2022 guidance will be available on the Investor Relations section of our website.

Before we begin, I would like to inform you that certain statements made by Insulet during the course of this call may be forward-looking, and could materially differ from current expectations. Please refer to the cautionary statements in our SEC filings for a detailed explanation of the inherent limitations of such statements.

We’ll also discuss non-GAAP financial measures with respect to our performance, namely adjusted operating margin, adjusted EBITDA and constant currency revenue, which is revenue growth, excluding the effect of foreign exchange. These measures align with what management uses as supplemental measures in assessing our operating performance, and we believe they are helpful to investors, analysts and other interested parties as measures of our operating performance from period to period.